LAG3 and melanoma: TIGIT has been shown to be highly expressed by TILs in melanoma patients (36) and in murine tumors, the most dysfunctional TIL phenotype is CD8+ T cells that co-express TIGIT, PD-1, Tim-3, and Lag-3 (37).